Here's Why Esperion Therapeutics Is Rocketing Higher By: Benzinga via Benzinga April 01, 2015 at 09:25 AM EDT UBS released a statement on Esperion Therapeutics Inc (NASDAQ: ESPR) after its analysis of the opportunity and likely utilization of ... Read More >> Related Stocks: Esperion Theraptc UBS Group Ag ADR